Precision System Science Co

Precision System Science Co Debt

The Debt of Precision System Science Co (7707.T) as of Sep 24, 2026 is 564.21 M JPY. In the previous year, Debt was 1.37 B JPY — a change of -58.87% (lower).

Debt

564.21 MJPY

YoY

-58.87%

Last updated:

In 2026, Precision System Science Co's total debt was 564.21 M JPY, a -58.87% change from the 1.37 B JPY total debt recorded in the previous year.

The Precision System Science Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
1.22 B JPY
Jan 1, 2019
963.92 M JPY
Jan 1, 2020
1.01 B JPY
Jan 1, 2021
3.69 B JPY
Jan 1, 2022
4.03 B JPY
Jan 1, 2023
3.88 B JPY
Jan 1, 2024
1.37 B JPY
Jan 1, 2025
564.21 M JPY
The Precision System Science Co Debt history
YEARDebtYoY
564.21 MJPY-58.87%
1.37 BJPY-64.64%
3.88 BJPY-3.61%
4.03 BJPY+9.15%
3.69 BJPY+263.32%
1.01 BJPY+5.30%
963.92 MJPY-20.99%
1.22 BJPY-15.81%
1.45 BJPY+1.21%
1.43 BJPY-8.99%
1.57 BJPY+24.66%
1.26 BJPY—
Access this data via the Eulerpool API

Precision System Science Co Stock analysis

What does Precision System Science Co do? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Precision System Science Co's Debt Structure

Precision System Science Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Precision System Science Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Precision System Science Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Precision System Science Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Precision System Science Co stock

Debt of Precision System Science Co is 564.21 M JPY in 2026.

Debt of Precision System Science Co changed from 1.37 B JPY to 564.21 M JPY, representing a -58.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Precision System Science Co since 2006 – with annual values, charts, and detailed analysis.

Debt's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Precision System Science Co historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Precision System Science Co

All Key Metrics — Precision System Science Co